fbpx
22
Mar

Holiday Migraine Avoidance Tips

Since CGRP Antibodies cannot be found in anyone’s formulary yet, we’ll have to abide by the time honored trigger avoidance strategies during this holiday season.  Most agree the holiday season is meant to be a exceptionally joyful time of year. But a migraine can ruin the fun and celebration, and suck out the “joy”  for sure. Following are tips on

Read more

21
Mar

What Price for Migraine Relief?

I am going to assume that most of you taking the time to read this newsletter are aware of the four big Pharma companies competing to be the first to offer a drug that may lessen, or even prevent, migraines for the more than 36 million Americans affected by this debilitating neurological illness. A quick review: Alder Biopharmaceuticals, Eli Lilly, Amgen,

Read more

21
Mar

Intermittent FMLA: Protection for the Employed Chronic Migraine Sufferer

The subject of this month’s newsletter began with a conversation between myself and a Human Resources Specialist around coping with an employee’s pneumonia, her chronic absences, and whether or not to place her on Intermittent FMLA.  During this conversation the HR Specialist likened someone with migraine, having to take large amounts of time off, to our present case of extraordinary

Read more

21
Mar

Genetic Research: Moving Towards a Root Cause

Genetic investigations continue to make news in the world of migraine research.  As you may recall, last year (2016) our newsletter reported a number of major genetic advances.  In probably one of the best known to date, originally published in Nature Genetics, an international group of researchers isolated 38 genetic variants implicated in migraine, 28 of them previously unknown. This

Read more

21
Mar

Stigma, Revisited 2017

First, heartfelt congratulations to everyone who participated in the wealth of activities celebrating Migraine and Headache Awareness Month 2017 (MHAM) Thanks to all who worked on and participated in the Shades of Migraine and World Migraine Solidarity Day campaign. If you did not hear about this effort, initiated by the Association of Migraine Disorders, visit www.ShadesForMigraine.org to learn about it. The campaign was

Read more

21
Mar

Headache on the Hill 2018

This February will witness the eleventh anniversary of “Headache on the Hill” (HOH), the highly acclaimed annual advocacy event, sponsored by the Alliance for Headache Disorders Advocacy (AHDA), designed to draw attention to the need for increased funding for research into migraine disease, pain and other headache disorders.   In 2017, AHDA advocated to include NIH pain research as a component

Read more

21
Mar

Current Neuromodulation Devices

With all of the anticipation of CGRP blockers, the sober news is that they will not be a savior for all migraine sufferers. First, like all pharmaceutical agents, they will not work for all migraine sufferers. Secondly, CGRP blockers are expensive (the current guess is that they will cost roughly $1000 a month). That is a big bill for insurance

Read more

20
Mar

Migraine Solidarity Day – June 21

You may already know that migraine disease is more common than Alzheimer’s disease, Parkinson’s disease, epilepsy and multiple sclerosis combined.  And despite that fact, it receives a small fraction of the available neuroscience research funding. Not  surprisingly there are a very small number of neuroscience researchers who decide to take on migraine as a project, or devote a laboratory or professional

Read more

20
Mar

Migraine Awareness Month 2017

June 2017 marks National Migraine Awareness Month (#MHAM). This month long series of events promotes education, collaboration and general consciousness enhancing regarding the neurological affliction, migraine disease.   Enormous strides have been made over the last several years. Possibly 2017 will be the most significant year to date, since the advent of triptans in 1991, in the history of migraine

Read more

20
Mar

Migraine Advocacy Update

This February witnessed the tenth anniversary of “Headache on the Hill”, the highly successful annual advocacy event, sponsored by the Alliance for Headache Disorders Advocacy (AHDA),  designed to draw attention to the need for increased funding for migraines and related headache disorders. Apart from being the tenth consecutive advocacy year, this year was also remarkable for another reason: the passage

Read more

20
Mar

Migraine and Epilepsy

“Epilepsy is more than a seizure. It’s a life changing and threatening condition affecting the person and their families terribly.” (Julie Clark, Scotland, UK, 2017)    We can easily substitute migraine and headache into that quote . The result would be a commonly acknowledged expression assigned to migraine disease:  Migraine is more than a headache… which is also life changing and affects people’s lives terribly. Coincidence? Probably not.  It brings us to

Read more

20
Mar

Vestibular Migraine

The Vestibular Migraine Mystery    The medical community is just now waking up to the high prevalence of vestibular migraine (VM). Current estimates vary but VM appears to affect up to 1- 3% of the general population. 10% of all migraineurs may suffer from VM. And more than 50% of people complaining of dizziness have VM. We are talking about

Read more

20
Mar

Holiday Migraine Prevention Strategy

The holiday season is already hard upon us. For some it is a time for celebration-parties, eating and drinking, enjoying time with family, and all too often, stress, a recognized migraine trigger. Remember, there exists both good stress and bad stress, but in the end it is all stress.  For the migraineur this stress can be a prescription for a

Read more

20
Mar

Novel Approaches to Migraine Treatment

The last few years has seen a groundswell of promising research and innovative medications and devices designed to prevent or abort a migraine episode. The Association of Migraine Disorders reports on what we believe to be credible research and treatments that will withstand rigorous testing. When AMD refers  to “novel approaches” we do not mean two minute YouTube guided imagery

Read more

20
Mar

Anti-CGRP Medications: An Update

A  breakthrough year indeed! With CGRP antibodies leading the charge.   It has been over a year since we reported on the great promise of CGRP antibodies and the immense promise they hold for a true, scientifically validated, migraine prevention medication.  Our Twitter postings, for those that follow us, have kept pace with the developments, but it seems an opportune

Read more

10
Mar

5 Apps that might help you manage your migraines

It seems nowadays there is a computer app to accommodate nearly every need. The migraine world is no exception. In reviewing the various migraine app products two major and separate classes emerge. The first includes those applications allowing a migraineur to both record and interpret critical data. This data could include dietary information, sleep patterns, medications, stress levels, date/time and more.

Read more

9
Mar

Migraine Disease and the Americans with Disabilities Act (ADA)

“Merriam-Webster” definition of disability: “a physical, mental, cognitive, or developmental condition that impairs, interferes with, or limits a person’s ability to engage in certain tasks or actions or participate in typical daily activities and interactions”   Controversy surrounds the question of whether or not migraine disease, in any or all of its manifestations, rises to the level of a disability.

Read more

9
Mar

2017: A breakthrough year for migraine?

The last year has been one of enormous promise for the prevention and treatment of migraine disease. Vigorous clinical trials of CGRP antibodies being aggressively pursued by Big Pharma, groundbreaking genetics research, and new developments in the area of neuromodulation have all led a renowned  migraine expert, Dr. David Dodick, Chair of the American Migraine Foundation, to declare “2017 will be

Read more

9
Mar

Childhood Migraine Disorders Revisited

There are several reasons we are re-visiting this subject, the focus of a newsletter 8 months ago. First, recent tweets on this subject have shown an enormous interest in this oft misunderstood area of the migraine spectrum. Second, a recent study on medications for childhood migraine called into question their efficacy. Specifically, placebo was shown to be as effective as

Read more

9
Mar

Advances in Non-Drug Therapies for Migraine

If you follow our Twitter postings with any degree of regularity you may recognize many of the devices/procedures summarized here. It was the recent release of the Cefaly II device that caused me to think that our followers deserved an up-to-date look at the devices available, especially if one was looking to add it to their treatment regimen.  Migraine treatment

Read more

7
Jul

A Prospective Randomized Cross-over Trial of Nortiptyline and Topiramate

Full Project Title: A Prospective Randomized Cross-over Trial of Nortiptyline and Topiramatenin the initial Treatment of Vestibular Migraine Principal Investigator: Anthony Mikulec MD, MPH Professor, Chief, Otology and Nuerotology, Saint Louis University School of Medicine Update: Despite the high number of migraine patients in our clinics, it continues to be more challenging than anticipated to identify patients who have not previously

Read more